Clinical Trial Update: Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of flutamide, suramin, and hydrocortisone in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)
• Suramin (suramin)
• flutamide (flutamide)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED